Mark Elliott Boulding insider trades

Open-market stock purchases and sales by Mark Elliott Boulding, EXEC. VP AND CLO at PTC Therapeutics, Inc, from SEC Form 4 filings since Jan 28, 2014.

Recent trades

DateStockTradeValue
Aug 17, 2026PTCT PTC Therapeutics, IncSold$133K
Aug 17, 2026PTCT PTC Therapeutics, IncSold$70.6K
Aug 17, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Jul 6, 2026PTCT PTC Therapeutics, IncSold$44.6K
Jul 6, 2026PTCT PTC Therapeutics, IncSold$51.9K
Jul 6, 2026PTCT PTC Therapeutics, IncBought (not open market)$89.3K
Jul 6, 2026PTCT PTC Therapeutics, IncSold$26K
Jul 6, 2026PTCT PTC Therapeutics, IncSold$32.2K
Jul 6, 2026PTCT PTC Therapeutics, IncSold$87.4K
Jul 6, 2026PTCT PTC Therapeutics, IncSold$55.4K
Jul 6, 2026PTCT PTC Therapeutics, IncSold$64.4K
Jul 6, 2026PTCT PTC Therapeutics, IncSold$70.3K
Jul 6, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Jul 6, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Jun 17, 2026PTCT PTC Therapeutics, IncSold$518K
Jun 17, 2026PTCT PTC Therapeutics, IncSold$147K
Jun 17, 2026PTCT PTC Therapeutics, IncSold$134K
Jun 17, 2026PTCT PTC Therapeutics, IncSold$24.5K
Jun 17, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Jun 17, 2026PTCT PTC Therapeutics, IncBought (not open market)—
May 15, 2026PTCT PTC Therapeutics, IncSold$33.1K
May 15, 2026PTCT PTC Therapeutics, IncSold$170K
May 15, 2026PTCT PTC Therapeutics, IncBought (not open market)—
May 8, 2026PTCT PTC Therapeutics, IncSold$65.7K
May 8, 2026PTCT PTC Therapeutics, IncSold$151K

Companies traded

  • PTCT PTC Therapeutics, Inc: 167 sales, last Aug 17, 2026

Get free alerts when Mark Elliott Boulding files a new trade →